Assessing Renal Function in Patients With an Antibiotic Laden Spacer
NCT ID: NCT01683734
Last Updated: 2015-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
NCT01373099
One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection
NCT02734134
Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection
NCT01373112
Safety and Effectiveness of the HIT Reverse HRS
NCT05357378
One-Stage Exchange for Chronically Infected Total Hip Arthroplasty
NCT02825381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Renal Function Observation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ages 18+
3. Ability to adhere to follow up schedule
Exclusion Criteria
2. Age \<18
3. Previous history of infected Total Knee Arthroplasty or Total Hip Arthroplasty
4. History of renal failure or impaired renal function
5. Allergies to aminoglycosides or Vancomycin
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central DuPage Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Sporer, MD
Role: PRINCIPAL_INVESTIGATOR
RUSH University Medical Center; Central DuPage Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RUSH University Medical Center
Chicago, Illinois, United States
Central DuPage Hospital
Winfield, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nephro11-021-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.